Genes and metals: a deadly combination.
Wilson's disease is an autosomal recessive disease of copper metabolism, with an estimated prevalence of 1:30000. The most common presentations of WD are liver disease and neurological disturbance. For many years the diagnosis was based on the results of several clinical and biochemical tests, for which several limitations had been reported. In recent years the developments of new techniques in genetic and molecular biology have provided useful tools in the diagnosis of Wilson's disease. However, the presence of several mutations and the fact that most patients are compound heterozygote means that the problem is not completely resolved. Chelators and zinc salts have been largely used in the treatment of WD patients with a favorable outcome, but the debate continues as to the agents of first choice. Liver transplantation is a cure for patients with decompensated liver disease but its effect on the neurological outcome is still not clear.
Dhawan
A
A
Cliniques Universitaires de Saint-Luc, Département de Pédiatrie, Bruxelles.
Ferenci
P
P
Geubel
A
A
Houwen
R
R
Lerut
J
J
Sokal
E
E
D000293:Adolescent; D002614:Chelating Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003300:Copper / Q000097:blood / Q000652:urine; D005260:Female; D006085:Graft Survival; D006527:Hepatolenticular Degeneration / Q000235:genetics* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D017093:Liver Failure / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation; D008279:Magnetic Resonance Imaging; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome; D015032:Zinc / Q000627:therapeutic use
D002614:Chelating Agents; D003300:Copper; D015032:Zinc